• Australia

Australian Biotech Stocks Analysis

ASX:ATH
ASX:ATH
ASX:ATHBiotechs

We're Keeping An Eye On Alterity Therapeutics' (ASX:ATH) Cash Burn Rate

June 28, 2022
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
ASX:CSL
ASX:CSL
ASX:CSLBiotechs

Is CSL Limited's (ASX:CSL) Latest Stock Performance A Reflection Of Its Financial Health?

June 28, 2022
Most readers would already be aware that CSL's (ASX:CSL) stock increased significantly by 5.0% over the past week...
ASX:KZA
ASX:KZA
ASX:KZABiotechs

We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn

June 24, 2022
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
ASX:PAR
ASX:PAR
ASX:PARBiotechs

Here's Why We're Not Too Worried About Paradigm Biopharmaceuticals' (ASX:PAR) Cash Burn Situation

June 20, 2022
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
ASX:PTX
ASX:PTX
ASX:PTXBiotechs

Prescient Therapeutics (ASX:PTX) Is In A Strong Position To Grow Its Business

June 19, 2022
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
ASX:RGS
ASX:RGS
ASX:RGSBiotechs

This Insider Has Just Sold Shares In Regeneus Ltd (ASX:RGS)

June 19, 2022
Investors may wish to note that the Chief Scientific Officer & Executive Director of Regeneus Ltd , Graham Vesey...
ASX:ACW
ASX:ACW
ASX:ACWBiotechs

While shareholders of Actinogen Medical (ASX:ACW) are in the black over 3 years, those who bought a week ago aren't so fortunate

June 16, 2022
Actinogen Medical Limited ( ASX:ACW ) shareholders might understandably be very concerned that the share price has...
ASX:ARX
ASX:ARX
ASX:ARXBiotechs

Investors one-year losses grow to 37% as the stock sheds NZ$27m this past week

June 16, 2022
The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...
ASX:CUV
ASX:CUV
ASX:CUVBiotechs

Have Clinuvel Pharmaceuticals Limited (ASX:CUV) Insiders Been Selling Their Stock?

June 15, 2022
We'd be surprised if Clinuvel Pharmaceuticals Limited ( ASX:CUV ) shareholders haven't noticed that the Non-Executive...
  • 1
  • 2
  • 3
  • 4
  • 5
Next

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Company
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.